| [1] |
Silverberg JI, Guttman⁃Yassky E, Agner T, et al. Chronic Hand Eczema Guidelines from an Expert Panel of the International Eczema Council[J]. Dermatitis, 2021,32(5):319⁃326. DOI: 10.1097/DER.0000000000000659.
|
| [2] |
中国医师协会皮肤科医师分会科学委员会, 中国医师协会皮肤科医师分会变态反应性疾病专业委员会, 手部湿疹科研协作组, 等. 中国手部湿疹诊疗专家共识(2021版)[J]. 中华皮肤科杂志, 2021,54(1):19⁃26. DOI: 10.35541/cjd.20200281.
|
| [3] |
Thyssen JP, Schuttelaar M, Alfonso JH, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema[J]. Contact Dermatitis, 2022,86(5):357⁃378. DOI: 10.1111/cod.14035.
|
| [4] |
中国医师协会皮肤科医师分会过敏性疾病专业委员会. 斑贴试验临床应用专家共识(2020修订版)[J]. 中华皮肤科杂志, 2020,53(4):239⁃243. DOI: 10.35541/cjd.20190873.
|
| [5] |
Kim HJ, Bang CH, Kim HO, et al. 2020 Korean Consensus Guidelines for Diagnosis and Treatment of Chronic Hand Eczema[J]. Ann Dermatol, 2021,33(4):351⁃360. DOI: 10.5021/ad.2021.33.4.351.
|
| [6] |
马晓蕾, 赵征, 韩钢文, 等. 302例面部皮炎和手部湿疹患者60种中国基准系列半抗原斑贴试验结果分析[J]. 临床皮肤科杂志, 2021,50(9):531⁃535. DOI: 10.16761/j.cnki.1000⁃4963.2021.09.004.
|
| [7] |
Weidinger S, Novak N. Hand eczema[J]. Lancet, 2024,404(10470):2476⁃2486. DOI: 10.1016/S0140⁃6736(24)01810⁃5.
|
| [8] |
Nørreslet LB, Ingham AC, Agner T, et al. Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment[J]. J Eur Acad Dermatol Venereol, 2025,39(6):1118⁃1125. DOI: 10.1111/jdv.20366.
|
| [9] |
Bauer A, Brans R, Brehler R, et al. S2k guideline diagnosis, prevention, and therapy of hand eczema[J]. J Dtsch Dermatol Ges, 2023,21(9):1054⁃1074. DOI: 10.1111/ddg.15179.
|
| [10] |
Bentz P, Eyerich K, Weisshaar E. Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV⁃Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen[J]. J Dtsch Dermatol Ges, 2022,20(9):1233⁃1235. DOI: 10.1111/ddg.14850_g.
|
| [11] |
Oosterhaven J, Schuttelaar M. Responsiveness and interpretability of the Hand Eczema Severity Index[J]. Br J Dermatol, 2020,182(4):932⁃939. DOI: 10.1111/bjd.18295.
|
| [12] |
HECSI. HECSI Score[EB/OL]. [2025⁃07⁃18]. https://hecsiscore. com/.
|
| [13] |
Yüksel YT, Thoning H, Larsen LS, et al. Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI⁃75 and HECSI⁃90 as within⁃patient responder definitions[J]. Contact Dermatitis, 2025,92(1):51⁃60. DOI: 10.1111/cod.14699.
|
| [14] |
Bissonnette R, Warren RB, Pinter A, et al. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double⁃blind, phase 3 trials[J]. Lancet, 2024,404(10451):461⁃473. DOI: 10.1016/S0140⁃6736(24)01027⁃4.
|
| [15] |
Janstrup AK, Nørreslet LB, Toft⁃Hansen JM, et al. Assessment of hand eczema severity by patients using the hand eczema severity index (HECSI)[J]. J Eur Acad Dermatol Venereol, 2023,37(11):2349⁃2354. DOI: 10.1111/jdv.19329.
|
| [16] |
Silverberg JI, Agner T, Baranowski K, et al. Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA⁃CHE): a new clinician reported outcome measure of CHE severity[J]. Arch Dermatol Res, 2024,316(4):110. DOI: 10. 1007/s00403⁃024⁃02818⁃3.
|
| [17] |
Bentz P, Apfelbacher C, Akst W, et al. Self⁃reported versus physician⁃reported severity of chronic hand eczema: concordance analysis based on data from the German Chronic Hand Eczema Patient Long⁃Term Management Registry[J]. Acta Derm Venereol, 2023,103:adv00884. DOI: 10.2340/actadv.v103.5383.
|
| [18] |
Molin S, Larsen LS, Joensson P, et al. Development and psychometric validation of a patient⁃reported outcome measure to assess the signs and symptoms of chronic hand eczema: the Hand Eczema Symptom Diary (HESD)[J]. Dermatol Ther (Heidelb), 2024,14(3):643⁃669. DOI: 10.1007/s13555⁃024⁃01114⁃2.
|
| [19] |
Weisshaar E, Yüksel YT, Agner T, et al. Development and validation of a patient⁃reported outcome measure of the impact of chronic hand eczema on health⁃related quality of life: the Hand Eczema Impact Scale (HEIS)[J]. Dermatol Ther (Heidelb), 2024,14(11):3047⁃3070. DOI: 10.1007/s13555⁃024⁃01267⁃0.
|
| [20] |
Buhl T, Bauer A, Ehst BD, et al. Health⁃related quality of life in chronic hand eczema in a phase 2b trial of delgocitinib cream[J]. Dermatol Ther (Heidelb), 2025,15(5):1181⁃1193. DOI: 10.1007/s13555⁃025⁃01384⁃4.
|
| [21] |
Rönsch H, Drewitz KP, Atwater AR, et al. Consensus on core domains for hand eczema trials: signs, symptoms, control and quality of life[J]. J Eur Acad Dermatol Venereol, 2025,39(9):1588⁃1599. DOI: 10.1111/jdv.20671.
|
| [22] |
Dulon M, Skudlik C, Nübling M, et al. Validity and responsiveness of the Osnabrück Hand Eczema Severity Index (OHSI): a methodological study[J]. Br J Dermatol, 2009,160(1):137⁃142. DOI: 10.1111/j.1365⁃2133.2008.08870.x.
|
| [23] |
Ribet V, Mielewczyk E, Sirvent A, et al. A novel dermo⁃cosmetic product containing thermal spring water, sucralfate, copper sulfate, and zinc sulfate in the management of hand eczema[J]. Clin Cosmet Investig Dermatol, 2018,11:373⁃381. DOI: 10.2147/CCID.S157849.
|
| [24] |
Carlsson A, Svensson Å, Anderson CD, et al. Scoring of hand eczema: good reliability of Hand Eczema Extent Score (HEES)[J]. Acta Derm Venereol, 2017,97(2):193⁃197. DOI: 10.2340/00015555⁃2521.
|
| [25] |
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)⁃⁃a simple practical measure for routine clinical use[J]. Clin Exp Dermatol, 1994,19(3):210⁃216. DOI: 10.1111/j.1365⁃2230.1994. tb01167.x.
|
| [26] |
Oosterhaven J, Ofenloch RF, Schuttelaar M. Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ)[J]. Br J Dermatol, 2020,183(1):86⁃95. DOI: 10.1111/bjd.18558.
|
| [27] |
Solberg J, Quaade AS, Drici L, et al. The proteome of hand eczema assessed by tape stripping[J]. J Invest Dermatol, 2023,143(8):1559⁃1568. DOI: 10.1016/j.jid.2022.12.024.
|
| [28] |
Huang L, Tang WH, Attar R, et al. Remote assessment of eczema severity via AI⁃powered skin image analytics: a systematic review[J]. Artif Intell Med, 2024,156:102968. DOI: 10.1016/j.artmed.2024.102968.
|
| [29] |
Jaiyeoba O, Ogbuju E, Ataguba G. et al. State⁃of⁃the⁃art skin disease classification: a review of deep learning models[J]. Network Modeling Analysis in Health Informatics and Bioinformatics, 2025,1(14):9. DOI: 10.1007/s13721⁃024⁃00495⁃w.
|
| [30] |
Amruthalingam L, Mang N, Gottfrois P, et al. Objective hand eczema severity assessment with automated lesion anatomical stratification[J]. Exp Dermatol, 2023,32(4):521⁃528. DOI: 10.1111/exd.14744.
|
| [31] |
Menne T, Maibach H I. Hand eczema[M]. Boca Raton: CRC Press, 1993.
|
| [32] |
Yüksel YT, Agner T, Ofenloch R. New evidence on the minimal important change (MIC) for the Hand Eczema Severity Index (HECSI)[J]. Contact Dermatitis, 2021,85(2):164⁃170, DOI: 10.1111/cod.13828.
|